Skip to main content
Top
Published in: Neurosurgical Review 1/2024

01-12-2024 | Meningioma | Research

Single-cell transcriptome analysis upon ECM-remodeling meningioma cells

Authors: Wen-Qiang Che, Yu-Jiao Wang, Liu Yang, Hong-Qin Wang, Xiang-Yu Wang, Jun Lyu

Published in: Neurosurgical Review | Issue 1/2024

Login to get access

Abstract

Meningiomas are the most common tumours that primarily arise in the central nervous system, but their intratumoural heterogeneity has not yet been thoroughly studied. We aimed to investigate the transcriptome characteristics and biological properties of ECM-remodeling meningioma cells. Single-cell RNA sequencing (ScRNA-seq) data from meningioma samples were acquired and used for analyses. We conducted comprehensive bioinformatics analyses, including screening for differentially expressed genes (DEGs), Kyoto Encyclopedia of Genes and Genomes (KEGG) signaling pathway and Gene Ontology (GO) term enrichment analyses, Gene Set Enrichment Analysis (GSEA), protein–protein interaction (PPI) analysis, and copy number variation (CNV) analysis on single-cell sequencing data from meningiomas. Eighteen cell types, including six meningioma subtypes, were identified in the data. ECM-remodeling meningioma cells (MGCs) were mainly distributed in brain-tumour interface tissues. KEGG and GO enrichment analyses revealed that 908 DEGs were mainly related to cell adhesion, extracellular matrix organization, and ECM-receptor interaction. GSEA analysis demonstrated that homophilic cell adhesion via plasma membrane adhesion molecules was significantly enriched (NES = 2.375, P < 0.001). CNV analysis suggested that ECM-remodeling MGCs showed considerably lower average CNV scores. ECM-remodeling MGCs predominantly localized at the brain-tumour interface area and adhere stably to the basement membrane with a lower degree of malignancy. This study provides novel insights into the malignancy of meningiomas.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ostrom QT, Patil N, Cioffi G, Waite K, Kruchko C, Barnholtz-Sloan JS (2020) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2013–2017. Neuro-Oncology 22(Supplement_1):iv1–iv96PubMedPubMedCentralCrossRef Ostrom QT, Patil N, Cioffi G, Waite K, Kruchko C, Barnholtz-Sloan JS (2020) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2013–2017. Neuro-Oncology 22(Supplement_1):iv1–iv96PubMedPubMedCentralCrossRef
2.
go back to reference Komori T (2017) The 2016 WHO classification of tumours of the central nervous system: the major points of revision. Neurol Med Chir 57(7):301–311CrossRef Komori T (2017) The 2016 WHO classification of tumours of the central nervous system: the major points of revision. Neurol Med Chir 57(7):301–311CrossRef
3.
go back to reference Olar A, Wani KM, Sulman EP, Mansouri A, Zadeh G, Wilson CD, DeMonte F, Fuller GN, Aldape KD (2015) Mitotic index is an independent predictor of recurrence-free survival in meningioma. Brain Pathol 25(3):266–275PubMedCrossRef Olar A, Wani KM, Sulman EP, Mansouri A, Zadeh G, Wilson CD, DeMonte F, Fuller GN, Aldape KD (2015) Mitotic index is an independent predictor of recurrence-free survival in meningioma. Brain Pathol 25(3):266–275PubMedCrossRef
4.
go back to reference Wang Z, Wang W, Xu S, Wang S, Tu Y, Xiong Y, Mei J, Wang C (2016) The role of MAPK signaling pathway in the Her-2-positive meningiomas. Oncol Rep 36(2):685–695PubMedPubMedCentralCrossRef Wang Z, Wang W, Xu S, Wang S, Tu Y, Xiong Y, Mei J, Wang C (2016) The role of MAPK signaling pathway in the Her-2-positive meningiomas. Oncol Rep 36(2):685–695PubMedPubMedCentralCrossRef
5.
go back to reference Sahm F, Schrimpf D, Olar A, Koelsche C, Reuss D, Bissel J, Kratz A, Capper D, Schefzyk S, Hielscher T (2016) TERT promoter mutations and risk of recurrence in meningioma. J Nat Cancer Inst 108(5):djv377PubMedCrossRef Sahm F, Schrimpf D, Olar A, Koelsche C, Reuss D, Bissel J, Kratz A, Capper D, Schefzyk S, Hielscher T (2016) TERT promoter mutations and risk of recurrence in meningioma. J Nat Cancer Inst 108(5):djv377PubMedCrossRef
6.
go back to reference Sievers P, Hielscher T, Schrimpf D, Stichel D, Reuss DE, Berghoff AS, Neidert MC, Wirsching H-G, Mawrin C, Ketter R (2020) CDKN2A/B homozygous deletion is associated with early recurrence in meningiomas. Acta Neuropathol 140:409–413PubMedPubMedCentralCrossRef Sievers P, Hielscher T, Schrimpf D, Stichel D, Reuss DE, Berghoff AS, Neidert MC, Wirsching H-G, Mawrin C, Ketter R (2020) CDKN2A/B homozygous deletion is associated with early recurrence in meningiomas. Acta Neuropathol 140:409–413PubMedPubMedCentralCrossRef
7.
go back to reference Sahm F, Schrimpf D, Stichel D, Jones DT, Hielscher T, Schefzyk S, Okonechnikov K, Koelsche C, Reuss DE, Capper DJTlo (2017) DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis. lancet oncol 18(5):682–694 Sahm F, Schrimpf D, Stichel D, Jones DT, Hielscher T, Schefzyk S, Okonechnikov K, Koelsche C, Reuss DE, Capper DJTlo (2017) DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis. lancet oncol 18(5):682–694
8.
go back to reference Choudhury A, Magill ST, Eaton CD, Prager BC, Chen WC, Cady MA, Seo K (2022) Lucas C-HG, Casey-Clyde TJ, Vasudevan HN: Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities. Nat Genet 54(5):649–659PubMedPubMedCentralCrossRef Choudhury A, Magill ST, Eaton CD, Prager BC, Chen WC, Cady MA, Seo K (2022) Lucas C-HG, Casey-Clyde TJ, Vasudevan HN: Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities. Nat Genet 54(5):649–659PubMedPubMedCentralCrossRef
9.
go back to reference Jovic D, Liang X, Zeng H, Lin L, Xu F, Luo Y (2022) Single-cell RNA sequencing technologies and applications: A brief overview. Clin Transl Med 12(3):e694PubMedPubMedCentralCrossRef Jovic D, Liang X, Zeng H, Lin L, Xu F, Luo Y (2022) Single-cell RNA sequencing technologies and applications: A brief overview. Clin Transl Med 12(3):e694PubMedPubMedCentralCrossRef
10.
go back to reference Wang AZ, Bowman-Kirigin JA, Desai R, Kang L-I, Patel PR, Patel B, Khan SM, Bender D, Marlin MC, Liu J (2022) Single-cell profiling of human dura and meningioma reveals cellular meningeal landscape and insights into meningioma immune response. Genome Med 14(1):1–25CrossRef Wang AZ, Bowman-Kirigin JA, Desai R, Kang L-I, Patel PR, Patel B, Khan SM, Bender D, Marlin MC, Liu J (2022) Single-cell profiling of human dura and meningioma reveals cellular meningeal landscape and insights into meningioma immune response. Genome Med 14(1):1–25CrossRef
11.
go back to reference Naba A, Clauser KR, Ding H, Whittaker CA, Carr SA, Hynes RO (2016) The extracellular matrix: Tools and insights for the “omics” era. Matrix Biol 49:10–24PubMedCrossRef Naba A, Clauser KR, Ding H, Whittaker CA, Carr SA, Hynes RO (2016) The extracellular matrix: Tools and insights for the “omics” era. Matrix Biol 49:10–24PubMedCrossRef
12.
go back to reference Butler A, Hoffman P, Smibert P, Papalexi E, Satija R (2018) Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat Biotechnol 36(5):411–420PubMedPubMedCentralCrossRef Butler A, Hoffman P, Smibert P, Papalexi E, Satija R (2018) Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat Biotechnol 36(5):411–420PubMedPubMedCentralCrossRef
13.
14.
go back to reference Zhang X, Lan Y, Xu J, Quan F, Zhao E, Deng C, Luo T, Xu L, Liao G, Yan M (2019) Cell Marker: a manually curated resource of cell markers in human and mouse. Nucleic Acids Res 47(D1):D721–D728PubMedCrossRef Zhang X, Lan Y, Xu J, Quan F, Zhao E, Deng C, Luo T, Xu L, Liao G, Yan M (2019) Cell Marker: a manually curated resource of cell markers in human and mouse. Nucleic Acids Res 47(D1):D721–D728PubMedCrossRef
15.
go back to reference Young MD, Wakefield MJ, Smyth GK, Oshlack A (2010) Gene ontology analysis for RNA-seq: accounting for selection bias. Genome Biol 11(2):1–12CrossRef Young MD, Wakefield MJ, Smyth GK, Oshlack A (2010) Gene ontology analysis for RNA-seq: accounting for selection bias. Genome Biol 11(2):1–12CrossRef
17.
go back to reference Huang DW, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4(1):44–57PubMedCrossRef Huang DW, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4(1):44–57PubMedCrossRef
18.
go back to reference Huang DW, Sherman BT, Lempicki RA (2009) Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 37(1):1–13PubMedCrossRef Huang DW, Sherman BT, Lempicki RA (2009) Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 37(1):1–13PubMedCrossRef
19.
go back to reference Mowery CT, Reyes JM, Cabal-Hierro L, Higby KJ, Karlin KL, Wang JH, Kimmerling RJ, Cejas P, Lim K, Li H (2018) Trisomy of a Down syndrome critical region globally amplifies transcription via HMGN1 overexpression. Cell Rep 25(7):1898–1911PubMedPubMedCentralCrossRef Mowery CT, Reyes JM, Cabal-Hierro L, Higby KJ, Karlin KL, Wang JH, Kimmerling RJ, Cejas P, Lim K, Li H (2018) Trisomy of a Down syndrome critical region globally amplifies transcription via HMGN1 overexpression. Cell Rep 25(7):1898–1911PubMedPubMedCentralCrossRef
20.
go back to reference Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, Simonovic M, Doncheva NT, Morris JH, Bork P (2019) STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res 47(D1):D607–D613PubMedCrossRef Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, Simonovic M, Doncheva NT, Morris JH, Bork P (2019) STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res 47(D1):D607–D613PubMedCrossRef
21.
go back to reference Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13(11):2498–2504PubMedPubMedCentralCrossRef Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13(11):2498–2504PubMedPubMedCentralCrossRef
22.
go back to reference Puram SV, Tirosh I, Parikh AS, Patel AP, Yizhak K, Gillespie S, Rodman C, Luo CL, Mroz EA, Emerick KS (2017) Single-cell transcriptomic analysis of primary and metastatic tumor ecosystems in head and neck cancer. Cell 171(7):1611–1624PubMedPubMedCentralCrossRef Puram SV, Tirosh I, Parikh AS, Patel AP, Yizhak K, Gillespie S, Rodman C, Luo CL, Mroz EA, Emerick KS (2017) Single-cell transcriptomic analysis of primary and metastatic tumor ecosystems in head and neck cancer. Cell 171(7):1611–1624PubMedPubMedCentralCrossRef
23.
go back to reference Tirosh I, Izar B, Prakadan SM, Wadsworth MH, Treacy D, Trombetta JJ, Rotem A, Rodman C, Lian C, Murphy G (2016) Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science 352(6282):189–196ADSPubMedPubMedCentralCrossRef Tirosh I, Izar B, Prakadan SM, Wadsworth MH, Treacy D, Trombetta JJ, Rotem A, Rodman C, Lian C, Murphy G (2016) Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science 352(6282):189–196ADSPubMedPubMedCentralCrossRef
24.
25.
go back to reference McGranahan N, Swanton C (2017) Clonal heterogeneity and tumor evolution: past, present, and the future. Cell 168(4):613–628PubMedCrossRef McGranahan N, Swanton C (2017) Clonal heterogeneity and tumor evolution: past, present, and the future. Cell 168(4):613–628PubMedCrossRef
27.
go back to reference Tsoi J, Robert L, Paraiso K, Galvan C, Sheu KM, Lay J, Wong DJL, Atefi M, Shirazi R, Wang X (2018) Multi-stage differentiation defines melanoma subtypes with differential vulnerability to drug-induced iron-dependent oxidative stress. Cancer Cell 33(5):890–904PubMedPubMedCentralCrossRef Tsoi J, Robert L, Paraiso K, Galvan C, Sheu KM, Lay J, Wong DJL, Atefi M, Shirazi R, Wang X (2018) Multi-stage differentiation defines melanoma subtypes with differential vulnerability to drug-induced iron-dependent oxidative stress. Cancer Cell 33(5):890–904PubMedPubMedCentralCrossRef
28.
go back to reference Petti AA, Williams SR, Miller CA, Fiddes IT, Srivatsan SN, Chen DY, Fronick CC, Fulton RS, Church DM, Ley TJ (2019) A general approach for detecting expressed mutations in AML cells using single cell RNA-sequencing. Nat Commun 10(1):3660ADSPubMedPubMedCentralCrossRef Petti AA, Williams SR, Miller CA, Fiddes IT, Srivatsan SN, Chen DY, Fronick CC, Fulton RS, Church DM, Ley TJ (2019) A general approach for detecting expressed mutations in AML cells using single cell RNA-sequencing. Nat Commun 10(1):3660ADSPubMedPubMedCentralCrossRef
29.
go back to reference Apra C, Peyre M, Kalamarides M (2018) Current treatment options for meningioma. Expert Rev Neurother 18(3):241–249PubMedCrossRef Apra C, Peyre M, Kalamarides M (2018) Current treatment options for meningioma. Expert Rev Neurother 18(3):241–249PubMedCrossRef
30.
go back to reference Achey RL, Gittleman H, Schroer J, Khanna V, Kruchko C, Barnholtz-Sloan JS (2019) Nonmalignant and malignant meningioma incidence and survival in the elderly, 2005–2015, using the Central Brain Tumor Registry of the United States. Neuro Oncol 21(3):380–391PubMedCrossRef Achey RL, Gittleman H, Schroer J, Khanna V, Kruchko C, Barnholtz-Sloan JS (2019) Nonmalignant and malignant meningioma incidence and survival in the elderly, 2005–2015, using the Central Brain Tumor Registry of the United States. Neuro Oncol 21(3):380–391PubMedCrossRef
31.
go back to reference Youngblood MW, Miyagishima DF, Jin L, Gupte T, Li C, Duran D, Montejo JD, Zhao A, Sheth A, Tyrtova E (2021) Associations of meningioma molecular subgroup and tumor recurrence. Neuro Oncol 23(5):783–794PubMedCrossRef Youngblood MW, Miyagishima DF, Jin L, Gupte T, Li C, Duran D, Montejo JD, Zhao A, Sheth A, Tyrtova E (2021) Associations of meningioma molecular subgroup and tumor recurrence. Neuro Oncol 23(5):783–794PubMedCrossRef
32.
go back to reference Pintea B, Boström A, Katsigiannis S, Gousias K, Pintea R, Baumert B, Boström J (2021) Prognostic Factors for Functional Outcome of Patients with Optic Nerve Sheath Meningiomas Treated with Stereotactic Radiotherapy-Evaluation of Own and Meta-Analysis of Published Data. Cancers 13(3):522PubMedPubMedCentralCrossRef Pintea B, Boström A, Katsigiannis S, Gousias K, Pintea R, Baumert B, Boström J (2021) Prognostic Factors for Functional Outcome of Patients with Optic Nerve Sheath Meningiomas Treated with Stereotactic Radiotherapy-Evaluation of Own and Meta-Analysis of Published Data. Cancers 13(3):522PubMedPubMedCentralCrossRef
34.
35.
go back to reference Patel AP, Tirosh I, Trombetta JJ, Shalek AK, Gillespie SM, Wakimoto H, Cahill DP, Nahed BV, Curry WT, Martuza RL (2014) Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science 344(6190):1396–1401ADSPubMedPubMedCentralCrossRef Patel AP, Tirosh I, Trombetta JJ, Shalek AK, Gillespie SM, Wakimoto H, Cahill DP, Nahed BV, Curry WT, Martuza RL (2014) Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science 344(6190):1396–1401ADSPubMedPubMedCentralCrossRef
36.
go back to reference Vasudevan HN, Choudhury A, Hilz S, Villanueva-Meyer JE, Chen WC (2022) Lucas C-HG, Braunstein SE, Oberheim Bush NA, Butowski N, Pekmezci M: Intratumor and informatic heterogeneity influence meningioma molecular classification. Acta Neuropathol 144(3):579–583PubMedPubMedCentralCrossRef Vasudevan HN, Choudhury A, Hilz S, Villanueva-Meyer JE, Chen WC (2022) Lucas C-HG, Braunstein SE, Oberheim Bush NA, Butowski N, Pekmezci M: Intratumor and informatic heterogeneity influence meningioma molecular classification. Acta Neuropathol 144(3):579–583PubMedPubMedCentralCrossRef
37.
40.
go back to reference Brooks SA, Lomax-Browne HJ, Carter TM, Kinch CE, Hall DMS (2010) Molecular interactions in cancer cell metastasis. Acta Histochem 112(1):3–25PubMedCrossRef Brooks SA, Lomax-Browne HJ, Carter TM, Kinch CE, Hall DMS (2010) Molecular interactions in cancer cell metastasis. Acta Histochem 112(1):3–25PubMedCrossRef
41.
go back to reference Bourboulia D (2010) Stetler-Stevenson WG: Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): positive and negative regulators in tumor cell adhesion. Semin Cancer Biol 20(3):161–168 Bourboulia D (2010) Stetler-Stevenson WG: Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): positive and negative regulators in tumor cell adhesion. Semin Cancer Biol 20(3):161–168
43.
go back to reference Wozniak MA, Modzelewska K, Kwong L, Keely PJ (2004) Focal adhesion regulation of cell behavior. Biochimica et Biophysica Acta (BBA)-Mol Cell Res 1692(2–3):103–119CrossRef Wozniak MA, Modzelewska K, Kwong L, Keely PJ (2004) Focal adhesion regulation of cell behavior. Biochimica et Biophysica Acta (BBA)-Mol Cell Res 1692(2–3):103–119CrossRef
44.
go back to reference Schmidt S, Friedl P (2010) Interstitial cell migration: integrin-dependent and alternative adhesion mechanisms. Cell Tissue Res 339(1):83–92PubMedCrossRef Schmidt S, Friedl P (2010) Interstitial cell migration: integrin-dependent and alternative adhesion mechanisms. Cell Tissue Res 339(1):83–92PubMedCrossRef
46.
go back to reference MacDonald JR, Ziman R, Yuen RKC, Feuk L, Scherer SW (2014) The Database of Genomic Variants: a curated collection of structural variation in the human genome. Nucleic Acids Res 42(D1):D986–D992PubMedCrossRef MacDonald JR, Ziman R, Yuen RKC, Feuk L, Scherer SW (2014) The Database of Genomic Variants: a curated collection of structural variation in the human genome. Nucleic Acids Res 42(D1):D986–D992PubMedCrossRef
47.
go back to reference Ballouz S, Dobin A, Gillis JA (2019) Is it time to change the reference genome? Genome Biol 20(1):1–9CrossRef Ballouz S, Dobin A, Gillis JA (2019) Is it time to change the reference genome? Genome Biol 20(1):1–9CrossRef
48.
go back to reference Pös O, Radvanszky J, Buglyó G, Pös Z, Rusnakova D, Nagy B, Szemes T (2021) DNA copy number variation: Main characteristics, evolutionary significance, and pathological aspects. Biomed J 44(5):548–559PubMedPubMedCentralCrossRef Pös O, Radvanszky J, Buglyó G, Pös Z, Rusnakova D, Nagy B, Szemes T (2021) DNA copy number variation: Main characteristics, evolutionary significance, and pathological aspects. Biomed J 44(5):548–559PubMedPubMedCentralCrossRef
49.
go back to reference Serin Harmanci A, Harmanci AO, Zhou X (2020) CaSpER identifies and visualizes CNV events by integrative analysis of single-cell or bulk RNA-sequencing data. Nat Commun 11(1):89ADSPubMedPubMedCentralCrossRef Serin Harmanci A, Harmanci AO, Zhou X (2020) CaSpER identifies and visualizes CNV events by integrative analysis of single-cell or bulk RNA-sequencing data. Nat Commun 11(1):89ADSPubMedPubMedCentralCrossRef
50.
go back to reference Ball MW, Gorin MA, Drake CG, Hammers HJ, Allaf ME (2017) The landscape of whole-genome alterations and pathologic features in genitourinary malignancies: an analysis of the cancer genome atlas. Eur Urol Focus 3(6):584–589PubMedPubMedCentralCrossRef Ball MW, Gorin MA, Drake CG, Hammers HJ, Allaf ME (2017) The landscape of whole-genome alterations and pathologic features in genitourinary malignancies: an analysis of the cancer genome atlas. Eur Urol Focus 3(6):584–589PubMedPubMedCentralCrossRef
51.
go back to reference Maynard A, McCoach CE, Rotow JK, Harris L, Haderk F, Kerr DL, Elizabeth AY, Schenk EL, Tan W, Zee A (2020) Therapy-induced evolution of human lung cancer revealed by single-cell RNA sequencing. Cell 182(5):1232–1251PubMedPubMedCentralCrossRef Maynard A, McCoach CE, Rotow JK, Harris L, Haderk F, Kerr DL, Elizabeth AY, Schenk EL, Tan W, Zee A (2020) Therapy-induced evolution of human lung cancer revealed by single-cell RNA sequencing. Cell 182(5):1232–1251PubMedPubMedCentralCrossRef
52.
53.
go back to reference Jeong Y, You D, Kang H-G, Yu J, Kim SW, Nam SJ, Lee JE, Kim S (2018) Berberine suppresses fibronectin expression through inhibition of c-Jun phosphorylation in breast cancer cells. J Breast Cancer 21(1):21–27PubMedPubMedCentralCrossRef Jeong Y, You D, Kang H-G, Yu J, Kim SW, Nam SJ, Lee JE, Kim S (2018) Berberine suppresses fibronectin expression through inhibition of c-Jun phosphorylation in breast cancer cells. J Breast Cancer 21(1):21–27PubMedPubMedCentralCrossRef
54.
go back to reference Jeon M, Lee J, Nam SJ, Shin I, Lee JE, Kim S (2015) Induction of fibronectin by HER2 overexpression triggers adhesion and invasion of breast cancer cells. Exp Cell Res 333(1):116–126PubMedCrossRef Jeon M, Lee J, Nam SJ, Shin I, Lee JE, Kim S (2015) Induction of fibronectin by HER2 overexpression triggers adhesion and invasion of breast cancer cells. Exp Cell Res 333(1):116–126PubMedCrossRef
55.
go back to reference Xiao J, Yang W, Xu B, Zhu H, Zou J, Su C, Rong J, Wang T, Chen Z (2018) Expression of fibronectin in esophageal squamous cell carcinoma and its role in migration. BMC Cancer 18(1):1–9CrossRef Xiao J, Yang W, Xu B, Zhu H, Zou J, Su C, Rong J, Wang T, Chen Z (2018) Expression of fibronectin in esophageal squamous cell carcinoma and its role in migration. BMC Cancer 18(1):1–9CrossRef
56.
go back to reference Barresi V, Simbolo M, Fioravanzo A, Piredda ML, Caffo M, Ghimenton C, Pinna G, Longhi M, Nicolato A, Scarpa AJC (2021) Molecular profiling of 22 primary atypical meningiomas shows the prognostic significance of 18q heterozygous loss and cdkn2a/b homozygous deletion on recurrence-free survival. Cancers 13(4):903 Barresi V, Simbolo M, Fioravanzo A, Piredda ML, Caffo M, Ghimenton C, Pinna G, Longhi M, Nicolato A, Scarpa AJC (2021) Molecular profiling of 22 primary atypical meningiomas shows the prognostic significance of 18q heterozygous loss and cdkn2a/b homozygous deletion on recurrence-free survival. Cancers 13(4):903
57.
go back to reference Williams EA, Santagata S, Wakimoto H, Shankar GM, Barker FG, Sharaf R, Reddy A, Spear P, Alexander BM, Ross JS (2020) Distinct genomic subclasses of high-grade/progressive meningiomas: NF2-associated, NF2-exclusive, and NF2-agnostic. Acta Neuropathol Commun 8:1–10CrossRef Williams EA, Santagata S, Wakimoto H, Shankar GM, Barker FG, Sharaf R, Reddy A, Spear P, Alexander BM, Ross JS (2020) Distinct genomic subclasses of high-grade/progressive meningiomas: NF2-associated, NF2-exclusive, and NF2-agnostic. Acta Neuropathol Commun 8:1–10CrossRef
58.
go back to reference Lindblom A, Ruttledge M, Collins VP, Nordenskjöld M, Dumanski JP (1994) Chromosomal deletions in anaplastic meningiomas suggest multiple regions outside chromosome 22 as important in tumor progression. Int J Cancer 56(3):354–357PubMedCrossRef Lindblom A, Ruttledge M, Collins VP, Nordenskjöld M, Dumanski JP (1994) Chromosomal deletions in anaplastic meningiomas suggest multiple regions outside chromosome 22 as important in tumor progression. Int J Cancer 56(3):354–357PubMedCrossRef
60.
go back to reference Xia Y, Liu Y, Yang C, Simeone DM, Sun T-T, DeGraff DJ, Tang M-s, Zhang Y, Wu X-R (2021) Dominant role of CDKN2B/p15INK4B of 9p21. 3 tumor suppressor hub in inhibition of cell-cycle and glycolysis. Nature Commun 12(1):2047ADSCrossRef Xia Y, Liu Y, Yang C, Simeone DM, Sun T-T, DeGraff DJ, Tang M-s, Zhang Y, Wu X-R (2021) Dominant role of CDKN2B/p15INK4B of 9p21. 3 tumor suppressor hub in inhibition of cell-cycle and glycolysis. Nature Commun 12(1):2047ADSCrossRef
61.
go back to reference Watson MA, Gutmann DH, Peterson K, Chicoine MR, Kleinschmidt-DeMasters BK, Brown HG, Perry A (2002) Molecular characterization of human meningiomas by gene expression profiling using high-density oligonucleotide microarrays. Am J Pathol 161(2):665–672PubMedPubMedCentralCrossRef Watson MA, Gutmann DH, Peterson K, Chicoine MR, Kleinschmidt-DeMasters BK, Brown HG, Perry A (2002) Molecular characterization of human meningiomas by gene expression profiling using high-density oligonucleotide microarrays. Am J Pathol 161(2):665–672PubMedPubMedCentralCrossRef
62.
go back to reference Giammalva GR, Brunasso L, Paolini F, Costanzo R, Bonosi L, Benigno UE, Ferini G, Sava S, Colarossi C, Umana GE (2022) The Long and Winding Road: An Overview of the Immunological Landscape of Intracranial Meningiomas. Cancers 14(15):3639PubMedPubMedCentralCrossRef Giammalva GR, Brunasso L, Paolini F, Costanzo R, Bonosi L, Benigno UE, Ferini G, Sava S, Colarossi C, Umana GE (2022) The Long and Winding Road: An Overview of the Immunological Landscape of Intracranial Meningiomas. Cancers 14(15):3639PubMedPubMedCentralCrossRef
63.
go back to reference Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM, Reifenberger G (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 23(8):1231–1251PubMedPubMedCentralCrossRef Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM, Reifenberger G (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 23(8):1231–1251PubMedPubMedCentralCrossRef
Metadata
Title
Single-cell transcriptome analysis upon ECM-remodeling meningioma cells
Authors
Wen-Qiang Che
Yu-Jiao Wang
Liu Yang
Hong-Qin Wang
Xiang-Yu Wang
Jun Lyu
Publication date
01-12-2024
Publisher
Springer Berlin Heidelberg
Published in
Neurosurgical Review / Issue 1/2024
Print ISSN: 0344-5607
Electronic ISSN: 1437-2320
DOI
https://doi.org/10.1007/s10143-024-02349-5

Other articles of this Issue 1/2024

Neurosurgical Review 1/2024 Go to the issue